2010
DOI: 10.1016/j.bcp.2010.05.017
|View full text |Cite
|
Sign up to set email alerts
|

CDC50A plays a key role in the uptake of the anticancer drug perifosine in human carcinoma cells

Abstract: . CDC50A plays a key role in the uptake of the anticancer drug perifosine in human carcinoma cells. Biochemical Pharmacology, Elsevier, 2010, 80 (6) This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be disco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 31 publications
(53 reference statements)
0
14
0
Order By: Relevance
“…TMEM30A -deficient cells are engulfed by macrophages because of the exposure of PS in the exoplasmic leaflet, and these cells lost the ability to induce tumor formation in nude mice 13 . TMEM30A also promotes uptake of the anticancer drugs and choline phospholipids into mammalian cells 38,39 . Most recently, a number of studies have highlighted the importance of TMEM30A in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…TMEM30A -deficient cells are engulfed by macrophages because of the exposure of PS in the exoplasmic leaflet, and these cells lost the ability to induce tumor formation in nude mice 13 . TMEM30A also promotes uptake of the anticancer drugs and choline phospholipids into mammalian cells 38,39 . Most recently, a number of studies have highlighted the importance of TMEM30A in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…TMEM30A also contributes to the uptake of anticancer drugs and choline phospholipids into mammalian cells(Muñozmartínez et al . ; Chen et al . ).…”
mentioning
confidence: 99%
“…The PCR was performed as following: initial denaturation at 95 °C for 5 min, 40 cycles for amplification at 95 °C for 30 s, 62 °C for 30 s and 72 °C for 30 s, final elongation at 72 °C for 5 min. Primer sequences were taken as described for ATP8B1 47 , CDC50A and β -Actin 48 . For the MGMT assay cells were treated with pre-warmed medium containing 10 µM O 6 BG-Glu for 15 min at 37 °C.…”
Section: Methodsmentioning
confidence: 99%